Genetic heritability of lung cancer is estimated to be 14% [1] , but only a few genetic risk loci have been identified to date in genome-wide association studies (GWAS) of lung cancer in Europeans [2] . Epidemiological studies have shown associations between lung cancer and cardiovascular disease (CVD) risk factors related to the metabolic syndrome [3, 4] . There is also substantial evidence that lipid metabolism and innate immunity evolved from common pathways and consequently genes that influence lipid traits may also influence inflammation and subsequent cancer development [5] [6] [7] . Lung cancer is also well-known to be strongly associated with tobacco smoking. Predicated on the hypothesis that investigating shared genetic risk factors across these traits could enhance the possibility to identify new genetic loci for lung cancer, we used quantile-quantile (Q-Q) plots [8] (Online Methods) to assess potential polygenic enrichment of SNPs associated with lung cancer given association with each CVD risk factor or smoking phenotypes (Figure 1 and Supplementary   Figure 1) .
The analysis was based on the TRICL consortium meta-analysis of lung cancer GWAS, including 12,160 lung cancer cases and 16,838 controls [2] ( Supplementary   Table 1 ); the meta-analysis data of blood lipids from the Global Lipids Genetics Consortium (GLGC, including genetic association with triglycerides (TG), and high and low density lipoproteins-cholesterol (HDL-C and LDL-C)) from 188,577 subjects
[9], of Type 2 diabetes (T2D) from 148,821 subjects [10] and of body mass index (BMI) from 123,865 subjects [11] ; and the meta-analysis of cigarettes per day (CPD) and never vs. ever smoking data from the Tobacco, Alcohol and Genetics (TAG) consortium, including 74,053 subjects (Supplementary Table 2 ). The Supplementary Materials (available online) contain additional details on the contributing studies, statistical analyses and functional tests.
The Q-Q plots show enrichment between lung cancer and LDL-C and between lung cancer and TG blood lipid traits across multiple p-value thresholds up to 10 -5 ( Figure   1A-B ) verified by an adaptive permutation procedure ( Supplementary Table 3 ). In contrast, we observed no significant enrichment (P<0.001) between lung cancer and HDL, BMI, T2D or smoking phenotypes (the analysis of smoking excluded the SNP markers mapping to chr15:78,686,690-79,231,478, which are known to be associated with lung cancer and smoking [12] [13] (Supplementary Table 3,  Supplementary Figure 1) . Thus we excluded these traits from further analysis.
Cross-phenotype associated loci between lung cancer and TG and between lung
cancer and LDL-C were assessed by conjunction false discovery rate (FDR) [8] (Supplementary Materials). Because controlling FDR is heavily affected by the number of identified SNPs, we pruned SNPs in linkage disequilibrium (LD) (r 2 >0. 8) and excluded the major histocompatibility complex (MHC) (genomic position (hg 19): chr6:29,528,318-33,373,649 [14] ), which harbors established lung cancer susceptibility SNPs and is known for long range LD. By controlling conjunction FDR, we identified one genetic locus at 6p22.1, rs6904596, A>G, Minor Allele Frequency in Caucasians=0.094, associated with both lung cancer and blood triglycerides (conjunction FDR=0.0124; P=5.5x10 -6 for lung cancer; P=1.39x10 -5 for TG (This locus and additional genetic loci shared between lung cancer and lipid traits are shown in Supplementary Table 4 and Supplementary Figures 2-6) . This locus remained significant also using different thresholds for pruning SNPs in LD (Supplementary Table 5 ).
We tested this SNP for replication in 6,097 lung cancer cases and 204,657 controls from deCODE, Harvard, Holland and Spain (Supplementary Table 6 ). This locus was replicated (Preplication=2.4×10 -4 ) and attained genome-wide significance for lung cancer risk in the meta-analysis of discovery and replication data (two-sided Pcombined=5.2x10 -9 , Pheterogeneity=0.91, Table 1 ). This SNP was also replicated in the association with TG in 71,113 independent samples from deCODE and Holland (twosided P=0.011, Pcombined=1.34 x 10 -6 , Table 1 ).
The SNP association with lung cancer was mostly driven by the squamous cell carcinoma subtype (P=2.8x10 -5 ) and not adenocarcinoma (P=0.06, Supplementary  Table 7 ). rs6904596 localizes to 6p22.1 (27,491,299 bp; hg19) and lies 50kb 5' of Zinc Finger Protein 184 (ZNF184). It shows expression-QTL in lung tissue [15] with HLA-DRB3 (β=-6.79, P=1.10x10 -11 ). Additionally, rs7749305, located on chr6:27,446,566 (r 2 =1 with rs6904596 in HapMap 3 of Caucasian populations), shows suggestive regulatory functions. This SNP showed the strongest association with lung cancer, but was not genotyped in the Global Lipid Consortium GWAS. It lies within a DNaseI hypersensitive region in small airway epithelial cells (SAEC) and A549 adenocarcinoma cells (ENCODE) and lies in a region hypomethylated in primary Alveolar Epithelial Cells (AEC) from our laboratory (Supplementary Figure 7) .
rs7749305 alternate allele C appears to create ATF3 and HIF1A binding sites. Similar findings are evident in adipocytes (ENCODE), extending the pleiotropic association between lung cancer and lipid traits to their function in respective tissue types.
Our study emphasizes that pleiotropic analysis of GWAS data of epidemiologicallyrelated traits can uncover hitherto unidentified genetic associations. Moreover, some GWAS of quantitative traits may be much larger than disease specific GWAS (like in the case of CVD risk factors vs. lung cancer), and thus may improve the likelihood to identify new loci for the disease with the smaller sample size. 
